Silverfin false false 31/12/2025 01/01/2025 31/12/2025 E Rouholamin 28/07/1995 P J Turner 28/07/1995 28 May 2026 The company does not trade but it holds shares in a subsidiary company, The Worcestershire Imaging Centre Limited.
The principal activity of the subsidiary is that of MRI scanning. 03083878 2025-12-31 03083878 bus:Director1 2025-12-31 03083878 bus:Director2 2025-12-31 03083878 2024-12-31 03083878 core:CurrentFinancialInstruments 2025-12-31 03083878 core:CurrentFinancialInstruments 2024-12-31 03083878 core:ShareCapital 2025-12-31 03083878 core:ShareCapital 2024-12-31 03083878 core:RetainedEarningsAccumulatedLosses 2025-12-31 03083878 core:RetainedEarningsAccumulatedLosses 2024-12-31 03083878 core:CostValuation 2024-12-31 03083878 core:CostValuation 2025-12-31 03083878 bus:OrdinaryShareClass1 2025-12-31 03083878 bus:OrdinaryShareClass2 2025-12-31 03083878 bus:OrdinaryShareClass3 2025-12-31 03083878 bus:OrdinaryShareClass4 2025-12-31 03083878 2025-01-01 2025-12-31 03083878 bus:FilletedAccounts 2025-01-01 2025-12-31 03083878 bus:SmallEntities 2025-01-01 2025-12-31 03083878 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 03083878 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 03083878 bus:Director1 2025-01-01 2025-12-31 03083878 bus:Director2 2025-01-01 2025-12-31 03083878 2024-01-01 2024-12-31 03083878 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 03083878 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 03083878 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 03083878 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 03083878 bus:OrdinaryShareClass3 2025-01-01 2025-12-31 03083878 bus:OrdinaryShareClass3 2024-01-01 2024-12-31 03083878 bus:OrdinaryShareClass4 2025-01-01 2025-12-31 03083878 bus:OrdinaryShareClass4 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 03083878 (England and Wales)

# DROITWICH MRI LIMITED

### Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

DROITWICH MRI LIMITED

## Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

DROITWICH MRI LIMITED

## COMPANY INFORMATION

For the financial year ended 31 December 2025
DROITWICH MRI LIMITED

## COMPANY INFORMATION (continued)

For the financial year ended 31 December 2025

DIRECTORS | E Rouholamin
| P J Turner

SECRETARY | P J Turner

REGISTERED OFFICE | Victoria Square
| Droitwich
| United Kingdom

COMPANY NUMBER | 03083878 (England and Wales)

ACCOUNTANT | S&W Partners (Manchester) Limited
| Pall Mall
| 1 Pollen Square
| 59 King Street
| Manchester
| M2 4PD

DROITWICH MRI LIMITED

## BALANCE SHEET

As at 31 December 2025
DROITWICH MRI LIMITED

## BALANCE SHEET (continued)

As at 31 December 2025

| Note | 31.12.2025 |  | 31.12.2024
|  | £ |  | £
Fixed assets |  |  |  |
Investments | 3 | 14,520 |  | 14,520
|  | 14,520 |  | 14,520
Current assets |  |  |  |
Cash at bank and in hand | 4 | 1 |  | 1
|  | 1 |  | 1
Creditors: amounts falling due within one year | 5 | ( 4,569) |  | ( 3,352)
Net current liabilities |  | (4,568) |  | (3,351)
Total assets less current liabilities |  | 9,952 |  | 11,169
Net assets |  | 9,952 |  | 11,169
Capital and reserves |  |  |  |
Called-up share capital | 6 | 600 |  | 600
Profit and loss account |  | 9,352 |  | 10,569
Total shareholders' funds |  | 9,952 |  | 11,169

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Droitwich MRI Limited (registered number: 03083878) were approved and authorised for issue by the Board of Directors on 28 May 2026. They were signed on its behalf by:

E Rouholamin Director |

DROITWICH MRI LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
DROITWICH MRI LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Droitwich MRI Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Victoria Square, Droitwich, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The functional currency of Droitwich MRI Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.
These financial statements are separate financial statements.

##### Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

#### 2. Employees

| 31.12.2025 |  | 31.12.2024
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including directors | 3 |  | 3

#### 3. Fixed asset investments

Investments in subsidiaries

| 31.12.2025
| £
Cost |
At 01 January 2025 | 14,520
At 31 December 2025 | 14,520
Carrying value at 31 December 2025 | 14,520
Carrying value at 31 December 2024 | 14,520

#### 4. Cash and cash equivalents

| 31.12.2025 |  | 31.12.2024
| £ |  | £
Cash at bank and in hand | 1 |  | 1

#### 5. Creditors: amounts falling due within one year

| 31.12.2025 |  | 31.12.2024
| £ |  | £
Amounts owed to Group undertakings | 2,698 |  | 2,518
Other creditors | 1,871 |  | 834
| 4,569 |  | 3,352

#### 6. Called-up share capital

| 31.12.2025 |  | 31.12.2024
| £ |  | £
Allotted, called-up and fully-paid |  |  |
150 A Ordinary shares of £ 1.00 each (31.12.2024: nil shares) | 150 |  | 0
150 B Ordinary shares of £ 1.00 each (31.12.2024: nil shares) | 150 |  | 0
150 C Ordinary shares of £ 1.00 each (31.12.2024: nil shares) | 150 |  | 0
150 D Ordinary shares of £ 1.00 each (31.12.2024: nil shares) | 150 |  | 0
| 600 |  | 0